← All indications
Immunoproliferative Disorders
Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.
Subtype terms (3)
More specific conditions that are subtypes of Immunoproliferative Disorders in the MeSH hierarchy.
- Hypergammaglobulinemia
- Lymphoproliferative Disorders
129 drugs (86 approved, 43 experimental)
- Paraproteinemias
29 drugs (23 approved, 6 experimental)
Drugs by status
Phase 3 trials (2)
Phase 2 trials (11)
Phase 1 trials (6)
Other trials (1)
Organizations
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (3)